AG01E16G

1336960-13-4 | GSK2193874

1336960-13-4
AG01E16G
sdsSDS
sdsCOA

Price

$0.00

WARNING This product is not for human or veterinary use.
Request For Quotation
CAS Number 1336960-13-4
Catalog Number AG01E16G(AGN-PC-0WNR17)
Chemical Name GSK2193874
IUPAC Name 7-bromo-N-(1-phenylcyclopropyl)-3-[(4-piperidin-1-ylpiperidin-1-yl)methyl]-2-[3-(trifluoromethyl)phenyl]quinoline-4-carboxamide
InChI InChI=1S/C37H38BrF3N4O/c38-28-12-13-30-32(23-28)42-34(25-8-7-11-27(22-25)37(39,40)41)31(24-44-20-14-29(15-21-44)45-18-5-2-6-19-45)33(30)35(46)43-36(16-17-36)26-9-3-1-4-10-26/h1,3-4,7-13,22-23,29H,2,5-6,14-21,24H2,(H,43,46)
InChI Key UIVOZBSCHXCGPS-UHFFFAOYSA-N
MDL Number MFCD28009510
Molecular Formula C37H38BrF3N4O
Molecular Weight 691.6230
SMILES O=C(NC1(C=2C=CC=CC2)CC1)C=3C=4C=CC(Br)=CC4N=C(C=5C=CC=C(C5)C(F)(F)F)C3CN6CCC(N7CCCCC7)CC6
Synonyms
7-bromo-N-(1-phenylcyclopropyl)-3-((4-piperidin-1-ylpiperidin-1-yl)methyl)-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxamide, GSK2193874, GSK2193874, 1336960-13-4, GSK 2193874, GSK-2193874, CHEMBL4073922, 3-([1,4'-Bipiperidin]-1'-ylmethyl)-7-bromo-N-(1-phenylcyclopropyl)-2-[3-(trifluoromethyl)phenyl]-4-quinolinecarboxamide, GTPL6465, SCHEMBL2404540, BDBM50232797, s8367, ZINC98052705, AKOS024458495, CS-7612, NCGC00370767-01, AK687390, HY-100720, A14201, Q27077882, GSK2193874GSK-2193874GSK 2193874, 3-(1,4'-Bipiperidin-1'-ylmethyl)-7-bromo-N-(1-phenylcyclopropyl)-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxamide, 7-bromo-N-(1-phenylcyclopropyl)-3-[(4-piperidin-1-ylpiperidin-1-yl) methyl]-2-[3-(trifluoromethyl)phenyl]quinoline-4-carboxamide, D03LVL, UIVOZBSCHXCGPS-UHFFFAOYSA-N, C000628859, 7-bromo-N-(1-phenylcyclopropyl)-3-((4-piperidin-1-ylpiperidin-1-yl)methyl)-2-(3-(trifluoromethyl)phenyl)quinoline-4-carboxamide,

Product Recommendations

CERTIFICATE OF ANALYSIS
Chemical Name: Batch Number:
Chemical Structure: CAS Registry No:
Product ID:
Manufacture Date:
Storage Temperature:
Formula:
Molecular Weight:
Quantity:
Analysis Data:
Test: Result:
Conclusion: The above product meets the specifications of Angene.
Analyst:Chase
Date:
Reviewed by:Jessie
Date:
Angene International Limited